Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diabetes, heart failure, and renal dysfunction: The vicious circles
Eugene Braunwald
Progress in Cardiovascular Diseases (2019) Vol. 62, Iss. 4, pp. 298-302
Closed Access | Times Cited: 211

Showing 1-25 of 211 citing articles:

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
European Heart Journal (2021) Vol. 42, Iss. 36, pp. 3599-3726
Open Access | Times Cited: 8910
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa McDonagh, Marco Metra, Marianna Adamo, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 1, pp. 4-131
Open Access | Times Cited: 1537
Mechanisms of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors
Thomas A. Zelniker, Eugene Braunwald
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 4, pp. 422-434
Closed Access | Times Cited: 418
Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Yiwen Li, Yanfei Liu, Shiwei Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 257
Gliflozins in the Management of Cardiovascular Disease
Eugene Braunwald
New England Journal of Medicine (2022) Vol. 386, Iss. 21, pp. 2024-2034
Closed Access | Times Cited: 174
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
Kåre I. Birkeland, Johan Bodegård, Jan W. Eriksson, et al.
Diabetes Obesity and Metabolism (2020) Vol. 22, Iss. 9, pp. 1607-1618
Open Access | Times Cited: 162
Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy
Jing Yang, Zhangsuo Liu
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 146
Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica
Theresa A. McDonagh, Marco Metra, Marianna Adamo, et al.
Revista Española de Cardiología (2022) Vol. 75, Iss. 6, pp. 523.e1-523.e114
Closed Access | Times Cited: 90
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
Muhammad Usman, Deepak L. Bhatt, Ishaque Hameed, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 7, pp. 447-461
Closed Access | Times Cited: 28
Association of Intensive Lifestyle Intervention, Fitness, and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus
Ambarish Pandey, Kershaw V. Patel, Judy Bahnson, et al.
Circulation (2020) Vol. 141, Iss. 16, pp. 1295-1306
Open Access | Times Cited: 94
Outcome trends in people with heart failure, type 2 diabetes mellitus and chronic kidney disease in the UK over twenty years
Claire Lawson, Samuel Seidu, Francesco Zaccardi, et al.
EClinicalMedicine (2021) Vol. 32, pp. 100739-100739
Open Access | Times Cited: 67
Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan
Takashi Kadowaki, Hiroshi Maegawa, Hirotaka Watada, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 12, pp. 2283-2296
Open Access | Times Cited: 57
The Wnt Signaling Pathway in Diabetic Nephropathy
Haiying Wang, Ran Zhang, Xinjie Wu, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 51
Global, regional, and national burden of kidney dysfunction from 1990 to 2019: a systematic analysis from the global burden of disease study 2019
Shu Zhang, Huifang Ren, Rong-Xin Du, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 24
Association between diabetes prevalence and weekend warrior activity patterns
Zihao Chen, Junqiang Jia, Jiayuan Tu, et al.
Public Health (2025) Vol. 240, pp. 97-103
Closed Access | Times Cited: 1
The risk of new-onset atrial fibrillation in patients with type 2 diabetes mellitus treated with sodium glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors
Ann Wan-Chin Ling, Cze-Ci Chan, Shao‐Wei Chen, et al.
Cardiovascular Diabetology (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 54
Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
Kåre I. Birkeland, Johan Bodegård, Amitava Banerjee, et al.
Diabetes Obesity and Metabolism (2020) Vol. 23, Iss. 1, pp. 75-85
Open Access | Times Cited: 53
Diabetes Mellitus and Heart Failure
Filippos Triposkiadis, Αndrew Xanthopoulos, Αlexandra Bargiota, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3682-3682
Open Access | Times Cited: 46
Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics
Miyesaier Abudureyimu, Xuanming Luo, Xiang Wang, et al.
Journal of Molecular Cell Biology (2022) Vol. 14, Iss. 5
Open Access | Times Cited: 38
Association between serum Klotho levels and the prevalence of diabetes among adults in the United States
Kai Wang, Yukang Mao, Miao Lu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 37
The effect of sodium-glucose cotransporter 2 inhibitors on biomarkers of inflammation: A systematic review and meta-analysis of randomized controlled trials
Dongmei Wang, J. Y. Liu, Ling Zhong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 30
Affordable oral proinsulin bioencapsulated in plant cells regulates blood sugar levels similar to natural insulin
Henry Daniell, Rahul Singh, Venkata Mangu, et al.
Biomaterials (2023) Vol. 298, pp. 122142-122142
Open Access | Times Cited: 18
Impact of baseline kidney function on the effects of sodium‐glucose co‐transporter‐2 inhibitors on kidney and heart failure outcomes: A systematic review and meta‐analysis of randomized controlled trials
Ernesto Maddaloni, Ilaria Cavallari, Ylenia La Porta, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 5, pp. 1341-1350
Closed Access | Times Cited: 17
Arylureidoaurones: Synthesis, in vitro α-glucosidase, and α-amylase inhibition activity
Mohammad Kazempour-Dizaji, Somayeh Mojtabavi, Arash Sadri, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106709-106709
Closed Access | Times Cited: 17
Chapter 1: The Burden of Heart Failure
Richard E. Pratley, Xuan Guan, Richard J. Moro, et al.
The American Journal of Medicine (2024) Vol. 137, Iss. 2, pp. S3-S8
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top